Drug Trial Radar · NCT06423794
BHV-7000 Open-Label Extension Bipolar Mania Study
Last checked: Nov 20, 2026Latest source record: Dec 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
94
Actual
Start
Jun 24, 2024
Primary completion
Apr 25, 2025
Study completion Apr 25, 2025
Sponsor
- Lead sponsor
- Biohaven Therapeutics Ltd.Industry
- Sponsor type
- Industry
- First posted
- May 21, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the long-term safety and tolerability of BHV-7000 in subjects with bipolar I disorder.
Conditions
- Bipolar Disorder
Interventions
BHV-7000Drug
BHV-7000 75 mg taken once daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Clinically Significant Laboratory AbnormalitiesTime frame: Up to 52 weeks
- Number of Participants With Serious AEs (SAEs), AEs Leading to Study Drug Discontinuation, and AEs judged to be related to study medicationTime frame: Up to 52 weeks
- Number of Participants With Vital Sign AbnormalitiesTime frame: Up to 52 weeks
- Number of Participants With Electrocardiogram (ECG) Abnormalities specific to QTc elevationTime frame: Up to 52 weeks
Locations
32 sites in 1 country. Site status is shown where the registry gives one.
Pillar Clinical Research, LLC
Bentonville, Arkansas
WIRG
Little Rock, Arkansas
WRN
Rogers, Arkansas
Advanced Research Center, Inc.
Anaheim, California
CIT LA
Bellflower, California
ProScience Research Group
Culver City, California
Cenexel CNS
Garden Grove, California
Synergy San Diego
Lemon Grove, California
NRC Research Institute
Orange, California
CIT IE
Riverside, California
Cenexel CNS
Torrance, California
Segal Trials - Larkin Behavioral Health Services-Inpatient & Early Phase Site
Hollywood, Florida
Cenexel - RCA
Hollywood, Florida
LCC Medical Research Inst
Miami, Florida
Floridian Neuroscience Institute
Miami Lakes, Florida
Segal Trials - Miami Lakes Medical Research-Inpatient & Early Phase Site
Miami Lakes, Florida
Neuroscience Research Institute
West Palm Beach, Florida
Atlanta Center for Medical Research
Atlanta, Georgia
CenExel iResearch, LLC
Decatur, Georgia
CenExel iResearch, LLC
Savannah, Georgia
Uptown Research Institute
Chicago, Illinois
Pillar Clinical Research
Chicago, Illinois
CBH Health
Gaithersburg, Maryland
Precise Clinical Research
Flowood, Mississippi
Arch Clinical Trials
St Louis, Missouri
Hassman Research Institute
Marlton, New Jersey
RBA
Staten Island, New York
Midwest Clinical Research Center
Dayton, Ohio
NBCR
North Canton, Ohio
Community Clinical Research, Inc.
Austin, Texas
InSite Clinical Research, LLC
DeSoto, Texas
Pillar Clinical Research, LLC
Richardson, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.